JP2012036221A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012036221A5 JP2012036221A5 JP2011244500A JP2011244500A JP2012036221A5 JP 2012036221 A5 JP2012036221 A5 JP 2012036221A5 JP 2011244500 A JP2011244500 A JP 2011244500A JP 2011244500 A JP2011244500 A JP 2011244500A JP 2012036221 A5 JP2012036221 A5 JP 2012036221A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- salt
- solvate
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 17
- 150000003839 salts Chemical class 0.000 claims 16
- 239000012453 solvate Substances 0.000 claims 16
- 239000012442 inert solvent Substances 0.000 claims 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 4
- 229910052801 chlorine Inorganic materials 0.000 claims 4
- 239000000460 chlorine Substances 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- -1 pyridyl N-oxide Chemical class 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- OJWYYSVOSNWCCE-UHFFFAOYSA-N 2-methoxyethyl hypofluorite Chemical compound COCCOF OJWYYSVOSNWCCE-UHFFFAOYSA-N 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 230000008447 perception Effects 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 0 Cc1cccc(N([C@](C2)I)C3=C2C(*)*C(CC2CCCC2)N3)c1* Chemical compound Cc1cccc(N([C@](C2)I)C3=C2C(*)*C(CC2CCCC2)N3)c1* 0.000 description 5
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10320784.8 | 2003-05-09 | ||
| DE10320784 | 2003-05-09 | ||
| DE10336183 | 2003-08-07 | ||
| DE10336183.9 | 2003-08-07 | ||
| DE102004004142A DE102004004142A1 (de) | 2003-05-09 | 2004-01-28 | 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine |
| DE102004004142.3 | 2004-01-28 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505294A Division JP2006525966A (ja) | 2003-05-09 | 2004-04-28 | ６−シクリルメチル−および６−アルキルメチル置換ピラゾロピリミジン類 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012036221A JP2012036221A (ja) | 2012-02-23 |
| JP2012036221A5 true JP2012036221A5 (enExample) | 2012-04-05 |
| JP5277303B2 JP5277303B2 (ja) | 2013-08-28 |
Family
ID=33420016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011244500A Expired - Lifetime JP5277303B2 (ja) | 2003-05-09 | 2011-11-08 | ６−シクリルメチル−および６−アルキルメチル置換ピラゾロピリミジン類 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2298773B1 (enExample) |
| JP (1) | JP5277303B2 (enExample) |
| CL (1) | CL2004000978A1 (enExample) |
| DE (1) | DE102004004142A1 (enExample) |
| MY (1) | MY148252A (enExample) |
| NZ (1) | NZ543812A (enExample) |
| PE (1) | PE20050201A1 (enExample) |
| RU (1) | RU2383546C2 (enExample) |
| TW (1) | TWI350836B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102234131B1 (ko) * | 2013-04-05 | 2021-04-01 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 피리디닐피라졸로퀴놀린 화합물 |
| KR20200010211A (ko) | 2017-06-01 | 2020-01-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Pde9 저해제를 포함하는 약제학적 조성물 |
| AU2018276565A1 (en) | 2017-06-01 | 2019-11-07 | Eisai R&D Management Co., Ltd. | Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil |
| AU2018276568A1 (en) | 2017-06-01 | 2019-11-07 | Eisai R&D Management Co., Ltd. | Dementia therapeutic agent combining pyrazoloquinoline derivative and memantine |
| TWI784006B (zh) | 2017-06-01 | 2022-11-21 | 日商衛材R&D企管股份有限公司 | 含有吡唑并喹啉衍生物之路易氏體症治療劑 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH396924A (de) | 1960-05-11 | 1965-08-15 | Ciba Geigy | Verfahren zur Herstellung von 4-Mercapto-pyrazolo(3,4-d)pyrimidinen |
| CH396926A (de) | 1960-05-11 | 1965-08-15 | Ciba Geigy | Verfahren zur Herstellung neuer Pyrazolopyrimidine |
| CH396927A (de) | 1960-05-11 | 1965-08-15 | Ciba Geigy | Verfahren zur Herstellung neuer Pyrazolopyrimidine |
| CH396925A (de) * | 1960-05-11 | 1965-08-15 | Ciba Geigy | Verfahren zur Herstellung neuer Pyrazolopyrimidine |
| DE1147234B (de) | 1960-05-11 | 1963-04-18 | Ciba Geigy | Verfahren zur Herstellung von 1-Isopropyl-4-hydroxy-6-benzyl-pyrazolo[3, 4-d]pyrimidin |
| DE1149013B (de) | 1960-05-11 | 1963-05-22 | Ciba Geigy | Verfahren zur Herstellung von 4-Oxo-4, 5-dihydro-pyrazolo-[3, 4-d]Pyrimidinen |
| DE1161281B (de) | 1960-05-11 | 1964-01-16 | Ciba Aktiengesellschaft, Basel (Schweiz) | Verfahren zur Herstellung von 1-Alkyl-6-aralkyl-pyrazoloÄ3,4-dÜ-pyrimidinen. |
| US3732225A (en) | 1970-07-23 | 1973-05-08 | Squibb & Sons Inc | Pyrazolo(3,4-d)pyrimidine derivatives |
| US3847908A (en) | 1973-03-05 | 1974-11-12 | Squibb & Sons Inc | 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines |
| ATE126207T1 (de) | 1989-01-26 | 1995-08-15 | Bayer Ag | Optisch aktive (meth)acrylsäure-derivate, ihre herstellung, ihre polymerisation zu optisch aktiven polymeren und deren verwendung. |
| RU2104216C1 (ru) * | 1994-01-10 | 1998-02-10 | Акционерное общество открытого типа "Таганрогский авиационный научно-технический комплекс им.Г.М.Бериева" | Замок |
| DE19709877A1 (de) | 1997-03-11 | 1998-09-17 | Bayer Ag | 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate |
| ES2233685T3 (es) * | 2000-08-01 | 2005-06-16 | Bayer Healthcare Ag | Inhibidores selectivos de pde 2 como medicamentos para mejorar la percepcion. |
| HUP0401998A2 (hu) * | 2001-11-02 | 2005-01-28 | Pfizer Products Inc., | PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető |
| HN2002000317A (es) * | 2001-11-02 | 2003-05-21 | Pfizer | Inhibidores de pde9 para tratamiento de trastornos cardiovasculares |
| DE10219435A1 (de) * | 2002-05-02 | 2003-11-13 | Bayer Cropscience Ag | Substituierte Pyrazolo-pyrimidin-4-one |
-
2004
- 2004-01-28 DE DE102004004142A patent/DE102004004142A1/de not_active Withdrawn
- 2004-04-28 EP EP10186283.7A patent/EP2298773B1/de not_active Expired - Lifetime
- 2004-04-28 NZ NZ543812A patent/NZ543812A/en not_active IP Right Cessation
- 2004-04-28 RU RU2005138339/04A patent/RU2383546C2/ru not_active IP Right Cessation
- 2004-05-07 TW TW093112841A patent/TWI350836B/zh not_active IP Right Cessation
- 2004-05-07 CL CL200400978A patent/CL2004000978A1/es unknown
- 2004-05-07 MY MYPI20041687A patent/MY148252A/en unknown
- 2004-05-07 PE PE2004000472A patent/PE20050201A1/es not_active Application Discontinuation
-
2011
- 2011-11-08 JP JP2011244500A patent/JP5277303B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017514830A5 (enExample) | ||
| JP2017519781A5 (enExample) | ||
| JP2013530150A5 (enExample) | ||
| JP2010530897A5 (enExample) | ||
| JP2019069966A (ja) | Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
| JP2009523146A5 (enExample) | ||
| JP2013529196A5 (enExample) | ||
| JP2012510502A5 (enExample) | ||
| JP2016510323A5 (enExample) | ||
| JP2008513498A5 (enExample) | ||
| JP2009263394A5 (enExample) | ||
| JP2015501820A5 (enExample) | ||
| MY165906A (en) | Phenothiazine diaminium salts and their use | |
| JP2012504133A5 (enExample) | ||
| JP2012036221A5 (enExample) | ||
| CY1108752T1 (el) | Παραγωγα πουρινης δρωντα ως αγωνιστες του α2α-υποδοχεα | |
| JP2013538683A5 (enExample) | ||
| JP2012530758A5 (enExample) | ||
| JP2011513410A5 (enExample) | ||
| JP2010155827A5 (enExample) | ||
| JP2010529994A5 (enExample) | ||
| JP2005538111A5 (enExample) | ||
| JP2012509265A5 (enExample) | ||
| JPWO2020054788A5 (enExample) | ||
| JP2013515037A5 (enExample) |